COVID-19:Biofourmis、デジタル治療(DTx)Gaido Healthを買収:from Takeda Pharmaceuticals(動画):  Biofourmis buys remote cancer monitoring startup Gaido Health:  Biofourmis收购远程癌症监测初创公司Gaido Health

COVID-19:Biofourmis、デジタル治療(DTx)Gaido Healthを買収:from Takeda Pharmaceuticals(動画): 
Biofourmis buys remote cancer monitoring startup Gaido Health: 
Biofourmis收购远程癌症监测初创公司Gaido Health

Biofourmis:

ボストンのヘルスケア分析・デジタル治療(DTx)AIスタートアップが、動き出しました。

MedCity News:

BiofourmisがTakeda Pharmaceuticalsから、癌モニタリング/Gaido Healthを買収、

両社は、更なる提供製品/事業分野の拡大を目指します。

US Health Systems Are Applying Precision Medicine:

Biofourmis primarily focused on monitoring and treating patients with heart conditions via wearables

its AI-powered platform,

providing physicians a fuller picture into patients’ heart health and paving the way for more accurate, personalized care.

a recent Center for Connected Medicine survey:

But its move into oncology is a smart one, considering $151 billion is spent annually on cancer care in the US —

oncology tops the list of use cases for precision medicine among US health systems with initiatives underway, per a recent Center for Connected Medicine survey.

The Gaido Health purchase:

is the latest in a spate of activity signaling that Biofourmis is casting a wide net across the healthcare ecosystem —

which should benefit the startup both during the coronavirus pandemic and beyond.

Business Insider

https://www.businessinsider.com/biofourmis-buys-remote-cancer-monitoring-startup-gaido-health-2020-4?utm_source=feedly&utm_medium=referral